This is an aggregated industry headline. Read the full story at Endpoints News →
House panel calls to ban China data from FDA drug trial applications
A powerful spending committee in Congress wants the FDA to ban the use of clinical trial data from China in future applications by drugmakers to test new treatments. The language was
By Endpoints News
· Apr 30, 2026
· via Endpoints News
Image: Endpoints News
Tags
policyformat:headlineheadlineEndpoints News
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from Policy
All Policy →
PolicySTAT News ↗
Mifepristone, involved in most abortions in the U.S., can now be distributed only in person and at clinics.…
PolicyBriefing
A judge approved Purdue Pharma’s criminal sentence, clearing the way for the company’s dissolution after years…